Simon, Christopher
- SEC CIK
- 0001674993
No open-market purchases or sales filed in the past year.
Current role at each company
- SHC Sotera Health CoDirectoras of May 27, 2026
- HAE Haemonetics CorpPresident & CEOas of May 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Simon, Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HAE Haemonetics Corp
President & CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 (view filing) | Jun 13 | 2 days | Simon, ChristopherPresident & CEO | SSale | −1.15K | $62.60 | −$71.9K | −0.5%213.7K after | |
| May 23, 2022 (view filing) | May 19 | 4 days | Simon, ChristopherPresident & CEO | SSale | −2.50K | $59.10 | −$147.5K | −1.1%214.9K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Simon, ChristopherPresident & CEO | SSale | −832 | $56.10 | −$46.7K | −0.4%191.3K after |